Solacutan 3%, Gel

7680666440025 CH-66644 Gel

Associated product:

SOLACUTAN gel 3 % tb 50 g
Solacutan 3%, Gel
Solacutan 3%, Gel
Solacutan 3%, Gel
1 / 3
google

Article details

Package size
50
Selling units
50
Measure
g
Galenic form
Gel
Galenic group
Salben

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/03/2021
Patient information leaflet
Français
16/03/2021
Patient information leaflet
Italien
16/03/2021
Summary of Product Characteristics
Allemand
16/03/2021
Summary of Product Characteristics
Français
16/03/2021
Summary of Product Characteristics
Italien
16/03/2021

Detailed composition

Substance Quantity Type Category
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
15.0 MG Substance HBESI

Reimbursement information

Public price
CHF 41.80
Specialties list
Yes
Generic
Yes
SL addition date: 01/10/2018

Authorization holder

Dermapharm AG

6331 Hünenberg

Authorization information

Swissmedic authorization number
66644
Drug name
Solacutan 3%, Gel
Galenic form
GELK
ATC Code
D11AX18
Authorization status
Z
Dispensing category
B
First authorization
12/03/2018
Authorization expiration date
31/12/9999
IT Number
10.99.0.
Domain
Human medicine
Field of application
Behandlung aktinische Keratose

Package details

Description (FR)
SOLACUTAN gel 3 % tb 50 g
Description (DE)
SOLACUTAN Gel 3 % Tb 50 g
Market launch
12/03/2018
Narcotic (BTM)
No

Original drug

Solaraze 3%, Gel
GTIN: 7680605800019
CHF 46.05
View original

Other package sizes (2)

SOLACUTAN gel 3 % tb 25 g
25 G
GTIN: 7680666440018
View
None
100 G
GTIN: None
Not in V1